The up-regulation of TANK-binding kinase 1 in head and neck squamous cell carcinoma

被引:0
|
作者
Wang, Yaping [1 ]
Lu, Zhongyuan [1 ]
Hu, Zhangwei [1 ]
Zheng, Anyuan [1 ]
Wang, Fei [1 ]
Xu, Yong [1 ]
Xiao, Bokui [2 ]
Chen, Chen [2 ]
Tao, Zezhang [1 ,2 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Otolaryngol Head & Neck Surg, Wuhan 430060, Hubei, Peoples R China
[2] Wuhan Univ, Renmin Hosp, Res Inst Otolaryngol Head & Neck Surg, Wuhan 430060, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
GEO dataset; head and neck squamous cell carcinoma (HNSCC); TANK; binding kinase 1 (TBK1); tissue microassay (TMA); biomarker; EPITHELIAL-MESENCHYMAL TRANSITION; THERAPEUTIC TARGET; NONCANONICAL IKKS; CANCER CELLS; TBK1; ACTIVATION; RESISTANCE;
D O I
10.21037/tcr.2017.08.01
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The purpose of the present study was to investigate the function of TANK-binding kinase 1 (TBK1) in head and neck squamous cell carcinoma (HNSCC) tumorigenesis and progression, and to clarify that whether TBK1 could be a biomarker for early diagnosis or even therapeutic target of HNSCC. Methods: We first analyzed the expression level of TBK1 mRNA in HNSCC using GEO datasets, and then the results were verified by tissue microarray (TMA). Finally, we suppressed TBK1 gene expression in FaDu and Cal-27 cells to investigate the cellular mechanism. Results: Results of GEO datasets and TMA showed that the expression level of TBK1 in HNSCC was higher than normal tissue. In FaDu/siTBK1 and Cal-27/siTBK1 cells, TBK1 protein expression was down regulated significantly and the proliferation rate decreased with apoptosis increased. Conclusions: TBK1 gene expression was important for HNSCC cell proliferation and might offer additional help for the early diagnosis of HNSCC and it might even be a meaningful therapeutic target, however the mechanisms and applicability still need further investigation.
引用
收藏
页码:679 / 686
页数:8
相关论文
共 50 条
  • [41] The clinical value of serum squamous cell carcinoma 1 and 2 in head and neck squamous cell carcinoma
    Yasumatsu, Ryuji
    Nakano, Takafumi
    Hashimoto, Kazuki
    Kogo, Ryunosuke
    Wakasaki, Takahiro
    Nakagawa, Takashi
    AURIS NASUS LARYNX, 2019, 46 (01) : 135 - 140
  • [42] TANK-Binding Kinase 1 (TBK1) as a novel cancer immunotherapy target
    Vishwakarma, Ajaykumar
    Sun, Yi
    Fu, Amina
    Robitschek, Emily
    Iracheta-Vellve, Arvin
    Stinson, Susanna
    Salem, Aliasger
    Manguso, Robert
    Jenkins, Russell
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [43] Knockdown of TANK-Binding Kinase 1 Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Molecular-Targeted Drugs
    Du, Fengxia
    Sun, Huiwei
    Sun, Fang
    Yang, Shiwei
    Tan, Haidong
    Li, Xiaojuan
    Chai, Yantao
    Jiang, Qiyu
    Han, Dongdong
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [44] Tank-binding kinase 1 associates with centrosomes and regulates microtubule dynamics and mitosis
    Pillai, Smitha R.
    Nguyen, Jonathan
    Johnson, Joseph
    Haura, Eric
    Coppola, Domenico
    Chellappan, Srikumar
    CANCER RESEARCH, 2015, 75
  • [45] TANK-Binding Kinase 1 in the Pathogenesis and Treatment of Inflammation-Related Diseases
    Hui, Lu
    Chen, Xiaolin
    Huang, Mengke
    Jiang, Yongmei
    Liu, Ting
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (05)
  • [46] Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma
    Bayo, Pilar
    Jou, Adriana
    Stenzinger, Albrecht
    Shao, Chunxuan
    Gross, Madeleine
    Jensen, Alexandra
    Grabe, Niels
    Mende, Christel Herold
    Rados, Pantelis Varvaki
    Debus, Juergen
    Weichert, Wilko
    Plinkert, Peter K.
    Lichter, Peter
    Freier, Kolja
    Hess, Jochen
    MOLECULAR ONCOLOGY, 2015, 9 (08) : 1704 - 1719
  • [47] Strong evidence for up-regulation of cyclooxygenase-1 in head and neck cancer
    Erovic, B. M.
    Woegerbauer, M.
    Pammer, J.
    Selzer, E.
    Grasl, M. Ch.
    Thurnher, D.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 (01) : 61 - 66
  • [48] Head and neck squamous cell carcinoma: a stratified follow-up program
    De Felice, Francesca
    Lei, Mary
    Oakley, Richard
    Lyons, Andrew
    Fry, Alastair
    Jeannon, Jean-Pierre
    Ricard, Simo
    Urbano, Teresa Guerrero
    ORAL ONCOLOGY, 2021, 118
  • [49] Analysis of oncogenic activities of protein kinase D1 in head and neck squamous cell carcinoma
    Liyong Zhang
    Zhihong Li
    Yehai Liu
    Shuping Xu
    Manuj Tandon
    Brittany Appelboom
    Courtney R. LaValle
    Simion I. Chiosea
    Lin Wang
    Malabika Sen
    Vivian W. Y. Lui
    Jennifer R. Grandis
    Q. Jane Wang
    BMC Cancer, 18
  • [50] The Use of Immune Regulation in Treating Head and Neck Squamous Cell Carcinoma (HNSCC)
    Wang, Che-Wei
    Biswas, Pulak Kumar
    Islam, Atikul
    Chen, Mu-Kuan
    Chueh, Pin Ju
    CELLS, 2024, 13 (05)